Clinical Trial Update: Donepezil HCl & Cognitive Deficits in Autism [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating donepezil hydrochloride for cognitive deficits in autism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autistic Disorder

Drugs mentioned

• Donepezil HCl (Donepezil hydrochloride)

Snippet

Sponsor: University of Pittsburgh | Conditions: Autistic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-10-05